Ausgabe 8/2017
Inhalt (10 Artikel)
Market approval for drugs in the EU: time to change direction?
Alessandro Curto, Katelijne van de Vooren, Livio Garattini
The place of DPP-4 inhibitors in the treatment algorithm of diabetes type 2: a systematic review of cost-effectiveness studies
Alexandre Baptista, Inês Teixeira, Sónia Romano, António Vaz Carneiro, Julian Perelman
Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale
Paul F. M. Krabbe, Elly A. Stolk, Nancy J. Devlin, Feng Xie, Elise H. Quik, A. Simon Pickard
Costs of dementia in the Czech Republic
Iva Holmerová, Jakub Hort, Robert Rusina, Anders Wimo, Michal Šteffl
A method to simulate incentives for cost containment under various cost sharing designs: an application to a first-euro deductible and a doughnut hole
D. Cattel, R. C. van Kleef, R. C. J. A. van Vliet
Hepatitis C disease transmission and treatment uptake: impact on the cost-effectiveness of new direct-acting antiviral therapies
Hayley Bennett, Jason Gordon, Beverley Jones, Thomas Ward, Samantha Webster, Anupama Kalsekar, Yong Yuan, Michael Brenner, Phil McEwan
Junior doctors’ medical specialty and practice location choice: simulating policies to overcome regional inequalities
Pedro Ramos, Hélio Alves, Paulo Guimarães, Maria A. Ferreira
The impact of minimum wages on population health: evidence from 24 OECD countries
Otto Lenhart
Cost effects of preterm birth: a comparison of health care costs associated with early preterm, late preterm, and full-term birth in the first 3 years after birth
Josephine Jacob, Moritz Lehne, Andrea Mischker, Normen Klinger, Claudia Zickermann, Jochen Walker
Switching gains and health plan price elasticities: 20 years of managed competition reforms in The Netherlands
Rudy Douven, Katalin Katona, Frederik T. Schut, Victoria Shestalova